Dr. Lal Path Labs quarterly results and financials

Dr. Lal Path Labs (LALPATHLAB)₹2,017+0.38%(9 Nov 2026 close)Healthcare Service Provider

Key facts

In the Jun 2026 quarter (consolidated), Dr. Lal Path Labs reported sales of ₹795 Cr, up 19.1% from Jun 2025, and net profit of ₹170 Cr, up 26.9% year on year. For the year to Mar 2026, sales were ₹2,755 Cr and net profit ₹510 Cr.

Sales (Jun 2026): ₹795 Cr
Net profit (Jun 2026): ₹170 Cr
Sales (FY Mar 2026): ₹2,755 Cr
Net profit (FY Mar 2026): ₹510 Cr
EPS (Jun 2026): ₹10.12
Borrowings (Mar 2026): ₹199 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Dr. Lal Path Labs quarterly results

₹ crore unless stated; each column is a quarter.

Dr. Lal Path Labs Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	599	538	543	600	658	596	601	668	729	658	701	795
Expenses	424	398	401	432	457	442	434	478	505	480	515	550
Operating Profit	179	141	145	171	203	154	170	193	225	180	188	249
OPM %	30.0%	26.0%	27.0%	28.0%	31.0%	26.0%	28.0%	29.0%	31.0%	27.0%	27.0%	30.9%
Other Income	18.06	18.07	18.06	21.09	22.11	25.10	26.09	28.10	25.10	−6.02	24.09	32.13
Interest	8.03	7.03	7.02	6.02	6.02	5.02	5.02	5.01	5.02	7.02	6.02	6.03
Depreciation	36.14	36.13	37.14	35.11	35.12	36.10	36.12	35.14	40.14	42.14	45.19	44.17
Profit before tax	152	116	120	150	183	138	153	181	204	124	160	229
Tax %	27.0%	29.0%	28.0%	28.1%	29.0%	29.0%	−1.0%	26.0%	25.0%	26.0%	17.0%	25.1%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−21.06	0.00	0.00
Net Profit	111	82.02	86.02	108	131	98.01	156	134	152	90.98	132	170
EPS (Rs)	6.54	4.88	5.05	6.38	7.72	5.77	9.27	7.91	9.00	5.39	7.83	10.12

Dr. Lal Path Labs profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Dr. Lal Path Labs Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	789	909	1,055	1,199	1,326	1,575	2,082	2,010	2,219	2,455	2,755	2,882
Expenses	581	674	793	910	986	1,143	1,524	1,527	1,615	1,762	1,976	2,050
Operating Profit	211	239	265	295	345	438	563	492	611	701	786	841
OPM %	26.0%	26.0%	25.0%	24.0%	26.0%	28.0%	27.0%	24.0%	27.0%	28.0%	28.0%	29.2%
Other Income	20.07	27.11	31.14	46.21	55.24	51.22	52.25	42.20	69.24	91.33	70.26	75.30
Interest	0.00	1.01	1.01	1.01	15.05	16.05	30.12	38.12	29.09	22.09	23.06	24.09
Depreciation	28.12	28.09	33.15	38.12	73.29	77.29	108	151	145	142	163	172
Profit before tax	201	237	261	301	310	393	474	343	504	624	668	716
Tax %	34.1%	34.0%	34.0%	33.1%	27.1%	25.1%	26.0%	30.1%	28.0%	21.0%	24.0%	—
Exceptional items	0.00	0.00	1.01	0.00	0.00	0.00	0.00	1.01	0.00	4.01	−17.03	−21.06
Net Profit	133	156	172	200	228	296	350	241	362	492	510	545
EPS (Rs)	7.98	9.32	10.25	11.96	13.54	17.48	20.68	14.34	21.41	29.15	30.11	32.34
Dividend payout %	15.0%	16.0%	22.0%	25.0%	44.0%	57.0%	29.0%	42.0%	0.0%	41.0%	68.0%	—

Dr. Lal Path Labs balance sheet

₹ crore, at each year end.

Dr. Lal Path Labs Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	54.90	82.90	82.83	82.87	82.86	82.85	82.85	82.99	82.94	82.89	83.89	168
Reserves	260	425	512	705	861	949	1,162	1,420	1,585	1,766	2,089	2,342
Borrowings	27.01	0.00	0.00	0.00	0.00	0.00	150	534	420	247	157	199
Other Liabilities	133	117	94.54	127	144	339	264	308	296	355	381	431
Total Liabilities	474	625	689	916	1,089	1,372	1,659	2,345	2,384	2,453	2,711	3,138
Fixed Assets	150	166	152	209	209	414	448	1,373	1,308	1,230	1,170	1,259
CWIP	0.99	3.99	17.99	10.01	3.01	10.99	9.99	14.99	4.99	5.99	2.99	6.99
Investments	38.04	64.09	106	145	185	164	59.04	65.03	150	114	327	423
Other Assets	285	390	413	553	692	783	1,141	891	921	1,103	1,211	1,449
Inventories	13.97	14.96	17.96	26.93	28.93	56.86	42.87	52.82	33.93	36.92	35.93	43.89
Trade receivables	30.92	35.89	41.86	40.88	52.85	50.85	66.80	84.72	70.74	76.79	87.72	111
Cash & equivalents	149	211	241	315	492	571	929	620	667	833	841	913
Total Assets	474	625	689	916	1,089	1,372	1,659	2,345	2,384	2,453	2,711	3,138

Dr. Lal Path Labs cash flow

₹ crore, for each year.

Dr. Lal Path Labs Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	122	159	171	197	219	283	397	446	455	534	568	635
Cash from investing activity	−113	−163	−137	−173	−100	−26.08	−212	−450	−288	−24.06	−304	−423
Cash from financing activity	−1.01	0.00	−32.01	12.99	−55.05	−190	−139	136	−283	−414	−334	−264
Net cash flow	7.97	−4.98	1.99	36.85	63.80	66.79	47.84	133	−114	96.64	−67.79	−49.84
Capex	34.96	43.95	51.95	71.96	41.99	79.98	59.92	476	44.94	56.96	53.99	173
Free cash flow	87.02	115	120	125	177	205	339	−28.01	413	479	516	463
CFO / OP %	112.1%	108.1%	102.1%	110.1%	110.1%	110.1%	115.1%	103.1%	115.1%	110.1%	105.1%	104.1%

Dr. Lal Path Labs ratios

Working-capital days and returns, by year.

Dr. Lal Path Labs Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	17	17	17	14	16	14	15	15	13	13	13	15
Inventory days	37	31	33	44	40	70	39	38	28	30	27	30
Days payable	90	89	97	106	111	144	132	107	127	151	127	123
Cash conversion cycle	−34	−41	−46	−46	−54	−59	−77	−53	−86	−107	−85	−78
Working capital days	−9	27	19	17	0	−19	−26	−54	−56	−46	−30	−29
ROCE %	48.0%	47.0%	43.0%	38.0%	35.0%	32.0%	33.0%	29.0%	18.0%	25.0%	29.0%	28.0%

Dr. Lal Path Labs: frequently asked questions

What are the latest quarterly results of Dr. Lal Path Labs?

For the Jun 2026 quarter, Dr. Lal Path Labs reported sales of ₹795 Cr, up 19.1% year on year and net profit of ₹170 Cr, up 26.9% year on year. The operating margin was 30.9%.

What is the annual revenue of Dr. Lal Path Labs?

Dr. Lal Path Labs' sales for the year to Mar 2026 were ₹2,755 Cr; over the last twelve months they were ₹2,882 Cr.

What is the net profit of Dr. Lal Path Labs?

Net profit for the year to Mar 2026 was ₹510 Cr, and ₹545 Cr over the last twelve months. Earnings per share over the same trailing period were ₹32.34.

How much debt does Dr. Lal Path Labs have?

Dr. Lal Path Labs reported borrowings of ₹199 Cr at Mar 2026, against cash and equivalents of ₹913 Cr.

What is the free cash flow of Dr. Lal Path Labs?

Cash from operations was ₹635 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹463 Cr.

Loading…